Gene · 3728
Papers2,067
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,067
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenomic signature of accelerated ageing in progeroid Cockayne syndrome. | Aging Cell | 2023 | 37688320 | PubTator, text mining | PubMed |
| TMT-Based Quantitative Proteomics Analysis Reveals Differentially Expressed Proteins between Different Sources of hMSCs. | Int J Mol Sci | 2023 | 37686351 | PubTator, text mining | PubMed |
| Spatial transformation of multi-omics data unlocks novel insights into cancer biology. | Elife | 2023 | 37669321 | PubTator, text mining | PubMed |
| New observation of severe tooth malformation in a female patient with ectodermal dysplasia due to the EDA splice acceptor variant c.742-2A>G. | Mol Genet Genomic Med | 2023 | 37665136 | PubTator, text mining | PubMed |
| The role of genetic testing in suspected fulminant myocarditis: A case report. | Mol Genet Metab Rep | 2023 | 37662494 | PubTator, text mining | PubMed |
| Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer. | Cancer Res Commun | 2023 | 37654625 | PubTator, text mining | PubMed |
| Clinical and Genetic Features of Korean Inherited Arrhythmia Probands. | Korean Circ J | 2023 | 37653714 | PubTator, text mining | PubMed |
| Left-dominant arrhythmogenic cardiomyopathy due to desmoplakin mutation: a case report. | ESC Heart Fail | 2023 | 37632291 | PubTator, text mining | PubMed |
| Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy. | J Clin Med | 2023 | 37629337 | PubTator, text mining | PubMed |
| Maturation and Function of the Intercalated Disc: Report of Two Pediatric Cases Focusing on Cardiac Development and Myocardial Hyperplasia. | J Cardiovasc Dev Dis | 2023 | 37623366 | PubTator, text mining | PubMed |
| LINC02015 modulates the cell proliferation and apoptosis of aortic vascular smooth muscle cells by transcriptional regulation and protein interaction network. | Cell Death Discov | 2023 | 37596272 | PubTator, text mining | PubMed |
| Biallelic truncating variants in children with titinopathy represent a recognizable condition with distinctive muscular and cardiac characteristics: a report on five patients. | Front Cardiovasc Med | 2023 | 37576110 | PubTator, text mining | PubMed |
| Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. | Front Immunol | 2023 | 37575240 | PubTator, text mining | PubMed |
| Novel Mutation Glu98Lys in Cardiac Tropomyosin Alters Its Structure and Impairs Myocardial Relaxation. | Int J Mol Sci | 2023 | 37569730 | PubTator, text mining | PubMed |
| Combined Salivary Proteome Profiling and Machine Learning Analysis Provides Insight into Molecular Signature for Autoimmune Liver Diseases Classification. | Int J Mol Sci | 2023 | 37569584 | PubTator, text mining | PubMed |
| Nomogram for predicting cardiac death and heart transplantation in arrhythmogenic right ventricular cardiomyopathy. | ESC Heart Fail | 2023 | 37563882 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection perturbs enhancer mediated transcriptional regulation of key pathways. | PLoS Comput Biol | 2023 | 37561814 | PubTator, text mining | PubMed |
| Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. | JCI Insight | 2023 | 37561594 | PubTator, text mining | PubMed |
| An analysis of interactions between three structurally diverse anthocyanidins, as well as their glucosides, and model biological membranes, albumin, and plasmid DNA. | Sci Rep | 2023 | 37558717 | PubTator, text mining | PubMed |
| Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma. | Heliyon | 2023 | 37554782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3728/papers?page=8